BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 28255864)

  • 1. Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients.
    Hawkins KA; Emadi N; Pearlson GD; Winkler AM; Taylor B; Dulipsingh L; King D; Pittman B; Blank K
    Metab Brain Dis; 2017 Jun; 32(3):849-857. PubMed ID: 28255864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-Visit Blood Pressure Variability and Progression of White Matter Hyperintensities Among Older People With Hypertension.
    van Middelaar T; Richard E; Moll van Charante EP; van Gool WA; van Dalen JW
    J Am Med Dir Assoc; 2019 Sep; 20(9):1175-1177.e1. PubMed ID: 31133472
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial distribution and cognitive impact of cerebrovascular risk-related white matter hyperintensities.
    Veldsman M; Kindalova P; Husain M; Kosmidis I; Nichols TE
    Neuroimage Clin; 2020; 28():102405. PubMed ID: 32971464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.
    Scharf EL; Graff-Radford J; Przybelski SA; Lesnick TG; Mielke MM; Knopman DS; Preboske GM; Schwarz CG; Senjem ML; Gunter JL; Machulda M; Kantarci K; Petersen RC; Jack CR; Vemuri P
    Stroke; 2019 Nov; 50(11):3037-3044. PubMed ID: 31510903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study.
    Bernal J; Schreiber S; Menze I; Ostendorf A; Pfister M; Geisendörfer J; Nemali A; Maass A; Yakupov R; Peters O; Preis L; Schneider L; Herrera AL; Priller J; Spruth EJ; Altenstein S; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Rostamzadeh A; Glanz W; Buerger K; Janowitz D; Ewers M; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Laske C; Munk MH; Spottke A; Roy N; Dobisch L; Dechent P; Scheffler K; Hetzer S; Wolfsgruber S; Kleineidam L; Schmid M; Berger M; Jessen F; Wirth M; Düzel E; Ziegler G
    Alzheimers Res Ther; 2023 May; 15(1):97. PubMed ID: 37226207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in the Prediction of Cerebrovascular Events With White Matter Hyperintensity.
    de Havenon A; Smith EE; Sharma R; Falcone GJ; Bangad A; Prabhakaran S; Sheth KN
    J Am Heart Assoc; 2023 Jul; 12(13):e029374. PubMed ID: 37345754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies.
    Hu HY; Ou YN; Shen XN; Qu Y; Ma YH; Wang ZT; Dong Q; Tan L; Yu JT
    Neurosci Biobehav Rev; 2021 Jan; 120():16-27. PubMed ID: 33188821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age Moderates Associations of Hypertension, White Matter Hyperintensities, and Cognition.
    Guevarra AC; Ng SC; Saffari SE; Wong BYX; Chander RJ; Ng KP; Kandiah N
    J Alzheimers Dis; 2020; 75(4):1351-1360. PubMed ID: 32417773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Long-Term Vascular Care on Progression of Cerebrovascular Lesions: Magnetic Resonance Imaging Substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care).
    van Dalen JW; Moll van Charante EP; Caan MWA; Scheltens P; Majoie CBLM; Nederveen AJ; van Gool WA; Richard E
    Stroke; 2017 Jul; 48(7):1842-1848. PubMed ID: 28596452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between systolic blood pressure variability with depression, cognitive decline and white matter hyperintensities: the 3C Dijon MRI study.
    Tully PJ; Debette S; Tzourio C
    Psychol Med; 2018 Jul; 48(9):1444-1453. PubMed ID: 28950920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort.
    Salvadó G; Brugulat-Serrat A; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Alzheimers Res Ther; 2019 Jan; 11(1):12. PubMed ID: 30678723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Score of Perivascular Space Dilatation and White Matter Hyperintensities in Patients with Normal Cognition, Mild Cognitive Impairment, and Dementia.
    Zdanovskis N; Platkājis A; Kostiks A; Šneidere K; Stepens A; Naglis R; Karelis G
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888606
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults.
    Shinto L; Lahna D; Murchison CF; Dodge H; Hagen K; David J; Kaye J; Quinn JF; Wall R; Silbert LC
    J Alzheimers Dis; 2020; 74(1):65-77. PubMed ID: 32176647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change.
    Fiford CM; Sudre CH; Pemberton H; Walsh P; Manning E; Malone IB; Nicholas J; Bouvy WH; Carmichael OT; Biessels GJ; Cardoso MJ; Barnes J;
    Neuroinformatics; 2020 Jun; 18(3):429-449. PubMed ID: 32062817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.
    Schoemaker D; Zanon Zotin MC; Chen K; Igwe KC; Vila-Castelar C; Martinez J; Baena A; Fox-Fuller JT; Lopera F; Reiman EM; Brickman AM; Quiroz YT
    Alzheimers Res Ther; 2022 Jun; 14(1):89. PubMed ID: 35768838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Sectional Association Between Cognitive Frailty and White Matter Hyperintensity Among Memory Clinic Patients.
    Sugimoto T; Ono R; Kimura A; Saji N; Niida S; Toba K; Sakurai T
    J Alzheimers Dis; 2019; 72(2):605-612. PubMed ID: 31594230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.